Doxorubicin Hydrochloride & Febrile neutropenia

13.4%

of users reported Febrile neutropenia

44.2%

also reported Severe reaction

59.5%

are men

Severe reaction

44.2%

Hospitalization

42.1%

Life-threatening condition

10.4%

Death

3.2%

Doxorubicin Hydrochloride: general information

0 - 9 years

5.6%

10 - 19 years

8.7%

20 - 29 years

5.5%

30 - 39 years

7.0%

40 - 49 years

9.6%

50 - 59 years

17.1%

60 - 69 years

28.3%

70 - 79 years

17.7%

80 - 89 years

0.6%